These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7034762)

  • 1. Spironolactone and hydroflumethiazide in the treatment of hypertension.
    Akbar FA; Boston PF; Chapman J; Pearce MY
    Br J Clin Pract; 1981 Sep; 35(9):317-21. PubMed ID: 7034762
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative study of spironolactone and hydroflumethiazide alone and together in the treatment of hypertension.
    Jamil MA
    Guys Hosp Rep; 1971; 120(3):207-19. PubMed ID: 4951058
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparative evaluation of aldactide and methyldopa in the management of benign essential hypertension.
    Nair KG; Jairam HN; Lal HM; Phaterpekar SJ
    J Assoc Physicians India; 1980; 28(1-2):7-13. PubMed ID: 7216969
    [No Abstract]   [Full Text] [Related]  

  • 4. A spironolactone-hydroflumethiazide combination in hypertension.
    Practitioner; 1971 Mar; 206(233):412-5. PubMed ID: 4929196
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antihypertensive effects of hydroflumethiazide and prazosin].
    Andersen GS
    Ugeskr Laeger; 1980 Jun; 142(24):1555-7. PubMed ID: 7414715
    [No Abstract]   [Full Text] [Related]  

  • 6. Aldactide and dytide.
    Drug Ther Bull; 1967 Oct; 5(21):82-3. PubMed ID: 6077512
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of essential arterial hypertension with a thiazide-spironolactone-reserpine derivative combination].
    Klepping C; Villand J
    J Med Lyon; 1971 Sep; 52(213):1139-41. PubMed ID: 4400152
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of benign essential hypertension with an association of spironolactone and thiabutazide: an open multicenter study in general practice (author's transl)].
    Rhomberg F; Leya A
    Schweiz Rundsch Med Prax; 1981 Dec; 70(50):2269-78. PubMed ID: 7031639
    [No Abstract]   [Full Text] [Related]  

  • 9. A double-blind evaluation of the therapeutic efficacy of salutensin versus hydropres-50 in essential hypertension.
    Cangiano JL; Bloomfield DK
    Curr Ther Res Clin Exp; 1970 Feb; 12(2):78-83. PubMed ID: 4984323
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of a spironolactone and althiazide combination (aldactacine) in Africans with benign essential hypertension.
    Pinto JM
    East Afr Med J; 1981 Jan; 58(1):44-50. PubMed ID: 7011783
    [No Abstract]   [Full Text] [Related]  

  • 11. Spironolactone and propranolol in the management of hypertension.
    Akbar fA; Pearce MY
    Br J Clin Pract; 1984 Mar; 38(3):110-4. PubMed ID: 6370284
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical evaluation of parenteral hydroflumethiazide--as a diuretc and an hypertensive agent.
    Damany SJ; Munshi SG; Shah RM
    J Assoc Physicians India; 1965 Nov; 13(11):847-50. PubMed ID: 5852367
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolic effects of propranolol and hydroflumethiazide treatment in Kenyans with mild to moderate essential hypertension.
    Yonga GO; Ogola EN; Orinda DA
    East Afr Med J; 1993 Nov; 70(11):696-700. PubMed ID: 8033771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of effect of single daily doses of reserpine and hydroflumethiazide evaluated by noninvasive technology in hypertensive patients.
    Gifford RW; Williams GW; Vidt DG; Bolen K; Acker C
    Cleve Clin Q; 1982; 49(4):209-18. PubMed ID: 7168911
    [No Abstract]   [Full Text] [Related]  

  • 15. Beta-adrenergic blockers in the treatment of hypertension--experience with propranolol at Ibadan, Nigeria.
    Olatunde A; Akinkugbe OO; Carlisle R
    East Afr Med J; 1977 Apr; 54(4):194-201. PubMed ID: 902626
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of essential hypertension with spironolactone with reference to the plasma renin activity].
    Esch I; Placheta P
    Wien Klin Wochenschr; 1973 Jun; 85(23):413-7. PubMed ID: 4575841
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the treatment of hypertension].
    Szadkowski D; Kann J
    Med Welt; 1965 Sep; 37():2119-21. PubMed ID: 5323936
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral thiazide diuretics in the treatment of hypertension in Nigeria.
    Salako LA
    West Afr Med J Niger Pract; 1971 Oct; 20(5):320-3. PubMed ID: 5136799
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum electrolytes during long term treatment of hypertension with thiazide diuretics in Nigerians.
    Salako LA
    West Afr Med J Niger Med Dent Pract; 1972 Aug; 21(4):104-5. PubMed ID: 4671290
    [No Abstract]   [Full Text] [Related]  

  • 20. A double-blind comparison of spironolactone and hydrochlorothiazide in hypertensive patients treated with metoprolol.
    Lavenius B; Hansson L
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):291-5. PubMed ID: 7049966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.